Prognostic markers and surrogate markers of clinical progression in HIV infection

被引：2

作者：

Churchill, DR

机构：

[1] Department of Genitourinary Medicine, Imperial College, School of Medicine at St Mary's, London W2 1PG, Norfolk Place

来源：

INTERNATIONAL JOURNAL OF STD & AIDS | 1997年 / 8卷 / 09期

关键词：

CD4 lymphocyte count; viral load; beta(2)-microglobulin; disease progression;

D O I：

10.1258/0956462971920776

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：552 / 557

页数：6

共 49 条

[1]

Aber V, 1996, LANCET, V348, P283, DOI 10.1016/S0140-6736(96)05387-1

[2]

BASS HZ, 1992, J ACQ IMMUN DEF SYND, V5, P215

[3] ACID DISSOCIATION INCREASES THE SENSITIVITY OF P24-ANTIGEN DETECTION FOR THE EVALUATION OF ANTIVIRAL THERAPY AND DISEASE PROGRESSION IN ASYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS INFECTED PERSONS [J].

BOLLINGER, RC ;

KLINE, RL ;

FRANCIS, HL ;

MOSS, MW ;

BARTLETT, JG ;

QUINN, TC .

JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (05) :913-916

[4] Increased plasma human immunodeficiency virus type 1 burden following antigenic challenge with pneumococcal vaccine [J].

Brichacek, B ;

Swindells, S ;

Janoff, EN ;

Pirruccello, S ;

Stevenson, M .

JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (06) :1191-1199

[5]

BRUNVEZINET F, 1996, 11 INT C AIDS VANC

[6] CD4-PERCENT IS THE BEST PREDICTOR OF DEVELOPMENT OF AIDS IN A COHORT OF HIV-INFECTED HOMOSEXUAL MEN [J].

BURCHAM, J ;

MARMOR, M ;

DUBIN, N ;

TINDALL, B ;

COOPER, DA ;

BERRY, G ;

PENNY, R .

AIDS, 1991, 5 (04) :365-372

[7] Antiretroviral therapy for HIV infection in 1996 - Recommendations of an international panel [J].

Carpenter, CCJ ;

Fischl, MA ;

Hammer, SM ;

Hirsch, MS ;

Jacobsen, DM ;

Katzenstein, DA ;

Montaner, JSG ;

Richman, DD ;

Saag, MS ;

Schooley, RT ;

Thompson, MA ;

Vella, S ;

Yeni, PG ;

Volberding, PA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (02) :146-154

[8] PLASMA VIREMIA IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTION [J].

COOMBS, RW ;

COLLIER, AC ;

ALLAIN, JP ;

NIKORA, B ;

LEUTHER, M ;

GJERSET, GF ;

COREY, L .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (24) :1626-1631

[9]

Cooper DA, 1997, LANCET, V349, P1413, DOI 10.1016/S0140-6736(97)04441-3

[10] SERUM P24 ANTIGEN LEVEL AS AN INTERMEDIATE END-POINT IN CLINICAL-TRIALS OF ZIDOVUDINE IN PEOPLE INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].

DEGRUTTOLA, V ;

BECKETT, LA ;

COOMBS, RW ;

ARDUINO, JM ;

BALFOUR, HH ;

RASHEED, S ;

HOLLINGER, FB ;

FISCHL, MA ;

VOLBERDING, P ;

GROUP, TACT .

JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (04) :713-721

← 1 2 3 4 5 →